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ABSTRACT 
 
Introduction: Cervical cancer is the most common malignancy after breast cancer in 
women worldwide. It accounts for 83% of all new cases and 85% cancer death in 
developing countries. In South Africa, cervical cancer is the common cancer in women 
with an annual crude incidence rate of 30.2 per 100,000 women and the highest rate 
were found to be in women between the ages of 66-69 years. Approximately 6800 
women in S.A face new case of cervical cancer while accounting for 3700 cancer death 
annually. Because of unequal access to the health facilities, socio-economic 
differences, HPV and HIV infection, the rate of cervical cancer in black women is higher 
(42.1%) compared to the low rate in white women. Because of the  name “cancer bush’ 
given to Sutherlandia Frutescence(S.F) plant by the traditional healers as well as 
Xhosas, Zulu, Sotho and cape Dutch for its anti-cancer activity, the plant was in this 
study to confirm its cytotoxic effect on the cervical cancer cell lines. 
Aim of the study: to evaluate the methanolic extracts of Sutherlandia Frutescens on 
cervical cancer cell lines. 
Materials and Methods: The MTT assay was performed to evaluate SiHa cell lines 
treated with methanolic extract of S.F (50µg/ml, 100µg/ml, 150µg/ml and 200µg/ml). 
The three compounds (Canavanine, GABA and Pinitol) were also evaluated for its 
anti-tumour activity. The cell growth was then showed in real time using Xcilligence. 
Flow cytometry was employed to determine the mode of action. Caspase 3/7 assay 
was performed to confirm if cell death was via caspase-dependent or independent 
and ATP was done to assess the ATP level in S.F treated cells.  
Results: MTT shows a significant decline in cells treated with 50µg/ml, 100µg/ml 
and 200µg/ml of the extract and 50µg/ml was concluded to be the concentration at 
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which 50% of the cells die. The ATP results are inconsistent with MTT result; the 
ATP level increased in S.F treated cells. Cell index which represents the quantitative 
measure of cell growth in real time decline upon treatment with 50µg/ml. Flow 
cytometry showed cells are dying by apoptosis and the cell cycle arrest is mostly in 
the S phase. The cell death was caspase-dependent as it shows an increased 
luminescence which is proportional to the number of caspase. The concentrations of 
the compounds used, Canavanine (1000µM, 1500µM and 2500µM), GABA (100µM, 
300µM and 500µM) and Pinitol (30µM, 90µM and 120µM) induce cell death and cell 
death shows to decrease after the maximum concentration. 
Conclusion: Sutherlandia Frutescence has proven with number of research that it 
induces cell death via apoptosis. After evaluating its cytotoxicity, the plant shows to 
be a promising anti-tumor agent that needs to be clinically proven. 
 
 
Keywords: Cervical cancer, Sutherlandia Frutescence and apoptosis
vi | Ms Rakoma M.A MSc Life Science 
 
TABLE OF CONTENTS 
DECLARATION……………………………………………………………………………..ii 
ACKNOWLEDGEMENT…………………………………………………………………....iii 
ABSTRACT…………………………………………………………………………………..iv 
KEYWORDS………………………………………………………………………………….v 
TABLE OF CONTENTS…………………………………………………………………….vi 
LIST OF FIGURES…………………………………………………………………………..x 
LIST OF TABLES…………………………………………………………………………...xi 
 
CHAPTER 1 INTRODUCTION AND LITERATURE 
REVIEW……………………………......................................................................................1 
 
1. Medicinal Plants…………………………………………………………………………….1
            
      
1.2 Sutherlandia Frutescens……………………………………………………………………………2  
             
1.2.1. Lcanavanine …………………………………………………………………………….4                       
         
1.2.2. GABA …………………………………………………………………………………..5
           
1.2.3. Flavanoid …………………………………………………………….…………………5
          
1.3. Mechanism of medicinal plants in cancer………………………………………………...6
        
vii | Ms Rakoma M.A MSc Life Science 
 
1.4. Cervical cancer……………………………………………………………………………6 
           
1.4.1 Incidence………………………………………………………………………………...6 
             
1.4.2 Causes of Cervical cancer ………………………………………………………………7
             
1.4.3 Human Papilomarvirus ………………………………………………………………....8
             
1.4.4 Prevention of Cervical cancer…………………………………………………………...9
             
1.4.5 Treatment of Cervical Cancer………………………………………………………….11
             
1.5. Apoptosis ……………………………………………………………………………….11
          
1.5.1. Introduction……………………………………………………………………………11 
           
1.5.2. Intrinsic Pathway………………………………………………………………………13 
          
1.5.3. Extrinsic Pathway……………………………………………………………………...16  
           
1.6. Bcl-Family………………………………………………………………………….........17  
          
1.7. Capases …………………………………………………………………………….........19
          
viii | Ms Rakoma M.A MSc Life Science 
 
1.8. Necrosis …………………………………………………………………………………21
          
1.9. Tumour Suppressor Genes ……………………………………………………………...24
        
1.9.1. Tp53…………………………………………………………………………………...24 
          
1.9.2. pRb……………………………………………………………………………….........26
  
1.10 AIMS AND OBJECTIVES……………………………………………………………..27
             
CHAPTER 2 MATERIALS AND METHODS…………………………………………..28
                         
2.1 Cervical cancer cell lines………………………………………………………………...28
              
2.2 Plant Extract…………………………………………………………………………..28
             
2.3 Cell Culture ……………………………………………………………………………...28
             
2.4 MTT assay………………………………………………………………………………..29
              
2.5 Flow cytometry…………………………………………………………………………..29
             
2.6 Phytochemical screening…………………………………………………………….......30
             
2.7 Caspase Activity………………………………………………………………………….31 
ix | Ms Rakoma M.A MSc Life Science 
 
 
2.8 ATP Assay………………………………………………………………………………..31 
      
 2.9 Statistical analysis……………………………………………………………………….31
  
CHAPTER 3 RESULTS……………………………………………………………………..32 
 
Introduction…………………………………………………………………………………..32 
3.1 Phytochemical compounds found from Methanolic and Aqueous extract of Sutherlandia 
Frutescence……………………………………………………………………………………………..32 
3.2 The effect of S.F extract on SiHa cells………………………………………………………….36
    
3.3 The effect of S.F methanolic extract on SiHa cell growth……………………………….38 
 
3.4 The effect of S.F methanolic extract on the Caspase activity of SiHa cell lines ………..40 
 
3.5 The effect of methanolic S.F extract on cell cycle and apoptosis………………………..43 
 
3.6 The effect of Compounds (Canavanine,GABA and Pinitol) on  the growth of SiHa 
cells…………………………………………………………………………………………...46 
 
3.7 The effect of S.F methanolic extract on the ATP level in SiHa cells…………………….49 
 
CHAPTER 4 DISCUSSION…………………………………………………………………52 
 
x | Ms Rakoma M.A MSc Life Science 
 
 CONCLUSION……………………………………………………………………………..57 
REFERENCE………………………………………………………………………………...58 
 
 
List of Figures 
 
  
Figure 1.1(a): Geographical distribution of Sutherlandia Frutesncens………………………….3 
Figure 1(b): The Sutherlandia Frutescens plant………………………………………………3 
Figure 1(c): Sutherlandia Frutescens flowers………………………………………………...4 
Figure 1.2: The Schematic representation of the pathways leading to cell death by 
apoptosis……………………………………………………………………………………...15 
Figure1.3. Simple schematic representation of extrinsic pathway…………………………...17 
Figure1.4: Involvement of procaspase-8 in death-receptor signalling. (A) Procaspase-8 is 
recruited to the CD95 or TRAIL DISC through the adaptor protein FADD………………...20 
Figure1.5. A diagram showing the biochemical and morphological characteristics of 
Apoptosis and Necrosis……………………………………………………………………....22 
Figure 3.1: The cytotoxic effect of methanol extract of S.F on SiHa………………………..37 
Figure 3.2: Xcelligence analysis of the effect of methanol extract on the cell growth on SiHa 
in real time……………………………………………………………………………………40 
Figure 3.3: The Caspase activity graph depicting the results after the cells were treated with 
0.5µM Taxol and IC50 from MTT……………………………………………………………42 
Figure 3.4(A): Flow Cytometry analysis of SiHa cell subjected to plant extract and 
Taxol………………………………………………………………………………………….44 
 
xi | Ms Rakoma M.A MSc Life Science 
 
Figure 3.4(B): Represents the Flow Cytometry analysis of SiHa cell subjected to plant extract 
and Taxol……………………………………………………………………………………..45 
Figure 3.5: The cytotoxic effect of methanol extract of Canavanine on SiHa………………48 
Figure 3.6: The cytotoxic effect of methanol extract of GABA on SiHa……………………48 
Figure 3.7: The cytotoxic effect of methanol extract of Pinitol on SiHa…………………….49 
Figure 3.8: The ATP level of the cells treated with IC50, Canavanine, Pinitol and 
GABA………………………………………………………………………………………..51 
 
LIST OF TABLES 
 
Table 3.1. Phytochemical compounds found from Methanol and Aqueous extracted S.F after 
Mass spectrophotometry 
………………………………………………………………………………………………32 
Table 3.1(A) Methanolic Extract………………………………………………..................32 
Table 3.1(B) Aqueous Extract……………………………………………………………….35 
 
 
 
 
 
 
 
 
 
 1 | Ms Rakoma M.A MSc Life Science 
 
Chapter 1: Introduction and Literature Review 
 
1.1. Medicinal Plants  
Many people worldwide especially in developing countries still trust in herbal 
medicines this accounts for 70-80% of the world’s population as per the World 
Health Organisation (WHO). Traditional medicines have sustained the health of 
millions of Africans over hundred years and they have long history of known usage in 
alleviating various sicknesses and cancer is not an exception (Balunas and Kinghorn 
2005).  
 
The search for an anti-cancer drug was initiated in the 1950’s by the discovery and 
development of vinca alkaloids, vinblastine, vincristine and podophyllotoxin (Cragg 
and Newman 2005) which are believed to cure various ailments such as respiratory, 
uterine diseases, fever, inflammation, arthritis, TB, reducing stress, relieving pain, 
and many other diseases. Since then medicinal plants have been selected randomly 
for assessment as anti-proliferating drug (Cragg and Newman 2005). More than 
3000 plants have been identified as anti-cancer drugs (Balunas and Kinghorn 2005, 
Chan 2003). Taxol, Camptothecin, epipodophyllotocin are the anti-cancer drugs 
developed from Taxus brevifolla (Taxaceae), Camptotheca (decuminata) Decne 
(Nyssaceae) and Podophyllum peltatum Linnaeus respectively. 
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1.2.  Sutherlandia Frutescens 
 
Sutherlandia Frutescens (S.F), an indigenous plant to South Africa belonging to the 
family of Galegeae (Van Wyk and Albrecht. 2008). The xhosas, zulu, sotho and cape 
dutch used the plant for various illness such as stomach ache, fever, internal cancer, 
diabetes and wounds (Van Wyk and Gericke 2000). Moshe et al. (1998) found that 
the decoction consumed as blood tonic have been used as a treatment for cough, 
uterine cancer and eye infection. The plant is closely related to Astragalus and 
Lessertia D.C Van Wyk and Albrecht (2008) and found in southern part of Namibia, 
southern eastern parts of Botswana, western, central and eastern parts of South 
Africa and most part of Lesotho (Van Wyk and Albrecht. 2008). The other name of 
the plant is cancer bush or “kankerbos for its anti-cancer activity. Sutherlandia 
Frutescens is a shrub with bitter, aromatic leaves that have varying height from 0.2-
2.5m (Van Wyk and Albrecht. 2008) with pinnately compound leaves compromising 
pubescent to white-tomentose. As the first head of the Edinburg Botanical gardens, 
James Sutherland was honoured by naming the plant after him whereas 
Frutescence means bush from a Latin word Frutex. The plant was found to contain 
L-canavanine, GABA, flavonoids, pinntol, tritepenoids saponnis and other 
compounds which have a history of boosting an immune system (Van Wyk and 
Albrecht 2008).  
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(a)  
  
(b)  
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(c)  
Figure 1.1: Geographical distribution of Sutherlandia Frutescence, (a), Geographical 
distribution in South Africa (b) The Sutherlandia Frutescens plant and (c) The flowers. 
Source: http://www.plantzafrica.com/medmonographs/sutherlfrut.pdf 
 
1.2.1. L-canavanine 
L-canavanine has the powerful effect on the disruption of the normal metabolic 
process of arginine stored in leguminous plants (Bell, 1958; Bell et al. 1978) and its 
anti-metabolic function as the protection against preys as well as against disease 
causing organisms (Rosenthal, 1977, 1992). This arginine antagonist has a role in 
inhibiting carcinogenesis in various cancers. The above findings was witnessed by 
Kruse and McCoy, 1958 who reported that canavanine together with arginine 
competed to ensure the growth requirements of Walker carcinosarcoma 256 cells is 
met. Later on Kruse et al. 1959 later showed that the arginine was part of the protein 
of the cancer cells and that the diminution content of the protein hydrolysate was the 
same as canavanine.  
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1.2.2. GABA 
The relationship between cancer and GABA was first established by Masaharu 
Tatsuta et al. (1990) when the team evaluated the role of GABA and N-methyl-N1-
nitro-N-nitrosoguanidine-induced gastric carcinogenesis. GABA acts as the gut 
hormone in the gastrointestinal tract known to regulate the development and growth 
of malignancy in gastrointestinal tumour. The diamine oxidase (DAO), an enzyme 
responsible for production of GABA outside CNS, is increased in various cancer and 
this results in high level of GABA in cancer cells. (Nicholson et al.2001). In addition 
to DAO, glutamic acid decarboxylase (GAD), an enzyme involved in GABA synthesis 
was found in mammary gland malignancies (Muzuikiewicz, 1999). The findings 
suggest that GABA could be contributing to the nine human neoplasms GABA was 
found in. 
 
 
1.2.3. Flavonoids 
Flavonoids are polyphenolic compounds that occur naturally in plants, they have 
been known for billions of years are mostly present in fruits and vegetables. They are 
also found in medicinal plants such as Sutherlandia Frutescens. Flavonoids function 
comes to play when the phase I metabolizing enzymes metabolically activates pro-
carcinogens which activates other intermediates that associates with nucleophiles 
causing cancer. Flavonoids then prevent the activation of phase I metabolizing 
enzymes such as CYP1A1 and CYP1A2 Marchand et al. (2000) Thus; they are likely 
to inhibit carcinogens and therefore inhibit tumour cell proliferation (Mutoh et al. 2000 
and Markovits et al. 1989). 
 
6 | Ms Rakoma M.A MSc Life Science 
 
1.3.  Mechanism of medicinal plants on cancer 
 
Despite the large commercialization of Sutherlandia Frutescens as informal anti-
cancer drugs, there is little phytochemical studies of the plant and no detailed studies 
of the chemical diversity have been published (Van Wyk and Albrecht, 2008; 
Mncwangi and Viljoen 2012). Although Moshe 1998 found the leaves of Sutherlandia 
Frutescens to contain six flavonoids, they have been unidentified and the 
mechanism is still unknown (Van Wyk and Albrecht 2008).  
 
Kundu (2005) observed an antitumor activity when methanol extracts of S.F inhibit 
the 12-O-tetradecanoylphorbol-13-acetate on the mouse skin. While Chinkwo (2005) 
has shown that the South African Sutherlandia Frutescens exhibited apoptotic 
activity on the CHO, Caski and jukart T lymphoma cells following treatment with the 
plant, Sutherlandia Frutescens extracts tested on monkey and human cells lines 
revealed that the plant is not toxic (Seier et al. 2002, Johnson et al. 2007).  
 
 
1.4 Cervical cancer 
1.4.1 Incidences 
Cervical cancer is one of the common malignancy after breast cancer in women 
worldwide (Liu et al.2009) The 83% of the cancer cases are new  and 85% accounts 
for death in developing countries (Liu et al. 2009). According to the American Cancer 
Society, 12, 340 new cases of cervical cancer will be diagnosed in the United States 
and about 4 030 women are estimated to die from cervical cancer. Cervical cancer 
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can be diagnosed as early as 15 years old and mostly the diagnosis is done between 
the ages of 30-69 years old (Van Schalwyk et al. 2008). 
 
Cervical cancer has the largest rate in South Africa as compare to other cancers 
affecting women, it affects 30.2 in 100,000 women and the highest rates were found 
to be in women between the ages of 66-69 years (Mqoqi et al. 2004). Approximately 
6800 women in S.A face new case of cervical cancer while accounting for 3700 
cancer death annually (Moqoqi et al. 2004). Because of unequal access to health 
facilities, socio-economic differences, HPV and HIV infection, the rate of cervical 
cancer in black women is higher (42.1%) compared to the low rate in white women 
(14.5%) (Mqoqi, 2004). South African women undergo cervical excision of 
premalignant condition and experience the premature delivery as a result of HPV 
infection (Talip et al. 2010).  
 
1.4.2 Causes of Cervical cancer 
It is difficult to pinpoint the major cause of cancer but it is believed to be caused by 
various factors from environmental factors such as radiation, a transition of lifestyle 
to the western life such as high consumption of alcohol and fatty food, oral 
contraceptives, hormonal and inheritance of mutant genes (Choene et al. 2012). 
There are two main types of cervical cancer, a squamous cell carcinoma and 
adenocarcinoma.  Of all the cervical cancer cases, 80-90% of the cases are as a 
result of squamous cell carcinoma. 
 
Oral contraceptives have been found to be the risk factor in the development of 
cervical cancer. Studies have shown that the chances of a woman who uses birth 
8 | Ms Rakoma M.A MSc Life Science 
 
control pills to develop cervical cancer are double than those who do not use the oral 
contraceptives (Moreno et al. 2002). The risk increases as the number of years of 
using the contraceptive pills increases (Moreno et al. 2002).  
 
Tobacco smoke is a promoter of cancer (Coker et al. 2002, Castle et al. 2002). 
Although the mechanism of how it affects the HPV during cervical cancer 
development is unclear, however it is believed that the tobacco by-products entering 
the blood stream damages the DNA of the cervix, while the HPV oncoprotein block 
the apoptosis and a cell cycle arrest (Cooker et al. 2002). HPV infected women who 
smoke are 4times more likely to die from cervical cancer than in a non-smoking 
woman (Wright et al. 2005).  
 
1.4.3 Human Papilomavirus  
 
Papillomaviruses are non-enveloped viruses with 8000 base pairs that are commonly 
transmitted sexually (Doorbar 2007). The virus has two stages, the early and late 
stages which are responsible for DNA replication, transcriptional regulation and 
transformation. The late gene controls the formation of capsid coat (Frazer, 2008). 
HPV has the ability to transform normal cells to cancer cells. The virus oncoprotein 
either promote cell proliferation and or loss of tumour suppressor gene function. 
Because of the high rate of HPV infection and low rate of cervical cancer 
development indicate there are additional genetic factors in progression of malignant 
phenotype (Ho et al, 1998).   
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E6 and E7 are the HPV oncoprotein involved in cancer development by turning-off 
tumour suppressor genes p53 and pRb gene function respectively (Botha and 
Dochez, 2012). The HR-HPV oncogene protein E6 bind to the p53 tumour 
suppressor gene in combination with the cellular ubiquitin ligase E6AP and causes 
p53 degradation through the ubiquitin-proteasome pathway (Massimi et al. 2008). E6 
can interfere with apoptosis through the association with the Bcl-family (Vogt et al. 
2006; Thomas and Banks, 1998) and again through the up-regulation of apoptosis 
protein inhibitors c-IAP2 and survivin by the mechanism involving NF-ĸb (James et 
al, 2006, Yuan et al. 2005). E7 is defined by Di Domenico et al, (2012) as a small 
protein that induces cell cycle arrest at the S phase by binding to the retinoblastoma 
protein (pRb) which releases the E2F. Dyson (1998) confirmed the degradation of 
pRb through the proteasome dependent pathway. 
 
1.4.4. Prevention of Cervical cancer 
 
Since the infection with HPV takes 10 to 20 years to progress to cervical cancer with 
different stages of cervical intraepithelial lesions (CIN) as the pre-cancer (zur 
Hausen. 2002), cervical cancer is easy to prevent. This can be done by various 
methods and the most common being a Papinicolao test (Pap smear) which is 
defined as the screening test to check the abnormality in the cervical canal of female 
reproductive organ. Pap smear is then followed by various diagnostic procedures 
depending on the nature of the abnormalities. One of the sensitive diagnostic 
procedures after Pap smear is Colposcopy defined by Chase et al. (2009) as a 
diagnostic procedure to illuminates the view of the cervix, the tissue of a vagina and 
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vulva to examine them for signs any signs of abnormalities. It differentiates the 
normal from abnormal cervix tissues and suggests biopsies for further examination. 
 
Cervical cancer is highly prevented with 90% success rate through Pap smear 
screening and vaccination. (Zhu et al. 2009) indicated that although Pap smear 
screening is playing an effective role in decreasing cervical cancer incidences, it 
does not assist when the HPV infection has progressed to CIN or cervical cancer. 
The screening helps in finding the pre-cancers before they develop into cervical 
cancer. There are still limitations in the screening hence there is an effort of 
improvement by using biological or molecular markers as adjunction in the existing 
screening procedure.  Because of incorrect detection of cervical cancer by HPV-DNA 
testing, the expression of E6/E7 is believed to be a promising method of detection in 
cervical cancer (Clavel et al. 2001). The finding was supported by Castle et al. 
(2007), Lie et al. (2005) & Molden et al. (2005) who also demonstrated that the 
expression of E6/E7 will also be a reliable method compared to the Pap smear and 
HPV-DNA testing.  
 
The other method used is genotyping which is the preferred method as it distinguish 
a benign serial transient infection from type-specific infection, HPV type of differing 
oncogenic potential (Shiffman et al, 2005), and it provides epidemiological 
information. Treatment facilities for progressed cervical cancer is limited in S.A, 
There are only 20 gynaecological oncologists in the country and a high demand for 
radiotherapy (Botha and Dochez 2012).  
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1.4.5. Treatment 
 Once the CIN has progressed to cancer, no vaccine or screening will assist in 
getting rid of the tumour. There are various treatment methods that are effective from 
treating CIN to advanced cervical cancer (Green 2006). The choice of the treatment 
depends on the stage of the tumour, the size, how far it has spread and the depth 
and often the treatment is combined. There are three most common treatments, this 
includes: surgery, radiotherapy and chemotherapy. In surgery, cryosurgery is often 
used in the pre-cancerous stage and not invasive cancer. The method uses intense 
cold to kills the abnormal cells by freezing them. Another surgery for pre-cancer 
treatment is the laser surgery where laser beam is used to burn off the abnormal 
cells and remove a surface lesion. 
 
Loop electrosurgical excision procedure (LEEP) uses an electric current passed 
through a wired loop to remove cancerous cells from the cervix. Hysterectomy is also 
used as a treatment of cancer to remove the uterus or cervix usually at the stage 1AI 
of the cervical cancer. However, most treatments are limited due to site effects that 
follow the treatment which leads to an alternative treatment that is safe for patients. 
And the results of many cancers is due to failed apoptosis and cell cycle machinery 
and by restoring the functioning of these process through agents, cancer can be 
combated. 
 
1.5.  Apoptosis 
1.5.1. Introduction 
Cell proliferation is required to renew tissues for various purposes such as healing 
wounds, fighting infections or removing unwanted cells that may never had a 
12 | Ms Rakoma M.A MSc Life Science 
 
function or lost function due to mutation. The cell proliferation goes through stages 
and along the way mutation can results due to environmental and genetical stimuli. 
The mutation or damage in the DNA signals the tumor suppressor genes to arrest 
the proliferation allowing the repair process to take place. The proliferation will 
proceed after the damages have been completely repaired. If it is impossible to 
repair the damages, the cell is subjected to cell death via apoptosis. This is to ensure 
the integrity of the cell is maintained at all times. 
Cell death occurs in both unicellular and multicellular organisms but it is understood 
more in multicellular organisms where it aid in sculpting the body parts during 
development, controlling the number of cells and eliminating the damaged cells.it 
has been defined by Kroemer et al, (2005) as an irreversible loss of plasma 
membrane integrity. Cell death occurs due to number of reasons including mutation 
which causes damages in the cell. Cell damage can be caused by various 
exogenous stimuli such as UV radiation which mutate the DNA and stabilize the p53, 
a tumor suppressor gene which play a role in inhibiting the formation of tumor 
(Batista 2009).  Martin (2012) indicated that 50 to 70 and 20 to 30 billion cell dies in 
an adult and a child respectively. According to Lawen, (2003), Apoptosis occur 20 
times faster than mitosis and is it therefore very crucial to maintain the balance 
between the two processes. An 80 year old person would have 1814kg of bone 
marrow and lymph nodes and a gut 16 km long if mitosis proceeds without cell death 
(Lawen, 2003). Apoptosis and Necrosis are the main types of cell death; both 
methods have an important role not only in the development and homeostasis of the 
cells but also in the pathogenesis of several diseases processes. 
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1.5.1.1 Apoptosis 
Apoptosis in Greek expresses falling off of petals from the flower and was first 
defined by Ker et al. (1972) as the cell death that results in apoptotic bodies that are 
destroyed by phagocytic bodies. It involves number of biochemical and physical 
changes in the nucleus, cytoplasm and plasma membrane (Lawen, 2003). According 
to Golstein and Kroemer (2006), all the mentioned morphological and biochemical 
characteristics of apoptosis occur before plasma membrane integrity is lost. 
Apoptosis is characterised by cell shrinkage, nuclear condensation, membrane 
blebbing as well as DNA fragmentation into approximately 200 base pairs fragments 
(Majno, 1995) and the apoptotic bodies are then engulfed by phagocytic cells 
(Chritop, 2003).The process usually results without inflammatory because cell 
contents are not released in to the neighbouring cells (King and Cidlowski, 1998) as 
compared to Necrosis where the release of necrotic cells alerts the innate immune 
system resulting in inflammation (Golstein and Kroemer, 2006).  
The biochemical characterization of apoptosis is the DNA cleavage in the nucleus 
leading to number of number of nucleosomal pieces exposure of phosphatidylserine 
and proteolytic cleavage various intra-cellular substrate (Zimmermann et al, 2001). 
Impairment of apoptotic pathway results in pathological defects such autoimmune 
diseases, neurodegeneration or cancer (Reed et al. 2001). Two types of apoptosis 
exists which are the mitochondrial pathway known as the intrinsic pathway and the 
receptor-mediated pathway known as extrinsic pathway. 
1.5.2 Intrinsic Pathway 
Intrinsic pathway occurs inside the mitochondria, it is controlled by the pro-apoptotic 
and anti-apoptotic proteins. Anti-apoptotic genes are found on the outer membrane 
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of the mitochondrion and the pro-apoptotic genes are found on the inner membrane 
of the mitochondrion as well as in the cytosol where they are inactive. Upon 
activation by the membrane pro-apoptotic protein in the cytosol, conformational 
changes results exposing the BH3 binding through proteolytic and dephosphorylation 
(Hengartner, 2000).  The pathway can be triggered by the stimuli within the cell; this 
can be the oxidative stress, cytotoxic drugs, high level of cystolic Ca+ or DNA 
damages (Karp 2008). The pro-apoptotic protein stimulates the opening of 
mitochondria to release cytochrome c as well as SMAC/DIABLO which binds to the 
apoptotic protease activating factor 1(Apaf-1).ATP is the driving force in the function 
of cytochrome c and APaf-1. Without ATP, cytochrome c and Apaf-1 becomes 
inactive therefore no apoptosis. The   Binding of Apaf-1 triggers the formation of 
apoptosome which consist of Apaf-1, cytochrome c, ATP and procaspases 9 on a 
ratio of 1:1.The activated caspase 9 is released from the complex to cleave and 
activate the caspase 3 (Budihardjo et al.1999) which then cleave the cellular 
substrate needed for processes leading to apoptosis (Ghobrial et al. 2005). The 
pathway is controlled at various steps, including the release of cytochrome c, the 
binding and hydrolysis of dATP by Apaf-1 and the inhibition of caspase activation by 
the proteins that belong to the inhibitor of apoptosis (IAP) (Budihardjo et al. 1999). 
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Figure1.2. The Schematic representation of the pathways leading to cell death by 
apoptosis (Favaloro et al. 2012) 
The apoptotic stimuli activates the release of cytochrome c which binds to Apaf-
1.The apoptosome consisting of cytochrome c, Apaf-1 and ATP triggers the 
recruitment and activation of pro-caspase-9 to caspase-9 which cleaves and 
activated caspase 3 leading to apoptosis. 
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1.5.3. Extrinsic Pathway 
The pathway as the name implies, initiates at the extracellular space where the 
death signals causes the ligand TNF1 (Tumor necrosis factor 1) and Fas among 
other ligands to bind to the receptor on the membrane. There are several cell surface 
that play a role in the extrinsic pathway of apoptosis which have a conserved 
cysteine repeats at their outer domain (Budihardjo et al.1999). Fas and TNFR1, the 
most studied death receptors in apoptosis, have the same region named the death 
domain. The death domain; TRADD (TNF receptor associated death domain) and 
FADD (Fas associated death domain) binds to the TNF and Fas respectively 
(Schneider, 2000) resulting in Death inducing signal complex (DISC). The complex 
activates pro-caspases 8 to caspases 8 which then cleaves the executioner caspase 
3 after the aspartate residue. The activated caspase 3 can cleave other cellular 
substrate including ICAD (inhibitor of caspase-activated DNase), ROCKI (Rho-
associated coiled-coil forming kinase I), poly polymerase and many other (Lawen, 
2003). 
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Figure 1.3. Simple schematic representation of extrinsic pathway.  
Fas ligand outside the membrane attach to Fas on the cell membrane and recruits death 
domain specific for Fas called FADD. The complex called DISC activates pro-caspases 8 to 
caspases 8 which then cleaves the executioner caspase 3. 
 
1.6. Bcl-2 Family 
 
 Reed (1997) discovered that intrinsic pathway is controlled by the balance of the 
anti-apoptotic and pro-apoptotic protein. Anti-apoptotic protein regulates apoptosis 
by blocking the permeability of mitochondrial thus preventing the release of 
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cytochrome c. High concentration of pro-apoptotic will stimulate the release of 
intermembrane protein and the mitochondrion membrane will not widen to release 
any protein in a case of low concentration as compared to high concentration of anti-
apoptotic protein.  
 
 There are more than 20 members of Bcl-2 family (Kuwana and Newmeyer 2003) 
who are classified into three groups, the Bcl-2, Bax and BH3 subfamily. The Bax and 
BH3 subfamily are pro-apoptotic which are Bax, Bak and Bok and Bad, Bid, Bik, Blk, 
Hrk, BNIP3 and BimL. The Bcl-2 subfamilies, the Anti-apoptotic are Bcl-2, Bcl-XL, 
Bcl-w, Mcl-1 and A1. The pro-apoptotic and anti-apoptotic proteins have a key role in 
the decision of cell to undergo cell death. Bax/bak, bad and bid are amongst the 
well-studied pro-apoptotic proteins in cancer research, they promote cell death by 
stimulating permeability of the mitochondria which releases cytochrome c upon 
stimulation. Mitochondrial permeability is made possible by two mechanisms; firstly 
by the permeability of mitochondrial mediated by Bcl-2 family protein and secondly 
by the induction on the mitochondrial permeably transition mainly through the 
release of Ca2+  from the endoplasmic reticulum stores (Newmeyer and Kuwana, 
2003 ).This results when bax foes under post translation modification translocate 
from the cytosol to the outer membrane of the mitochondria, oligomerize and leads 
to the permeability of the mitochondria (Singh, 2007). 
 
Bcl-2 family protein bax is believed to be the main pro-apoptotic protein to promote 
mitochondrial permeability releasing cytochrome c (Gross et al. 1999 and Newmeyer 
& Ferguson-Miller, 2003).The space in the mitochondria as a result of Bax is small to 
allow tiny proteins such as cytochrome c to pass through. Shimuzi et al. (1999) 
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believe that the membrane permeability occurs through the widening of voltage-
dependent anion channel (VDAC) enough for small protein to pass through. Wei et 
al. (2001) argued that bax alone is not enough to stimulate mitochondrial 
permeability. For mitochondria to be permeable the two proteins; bax and tbid are 
required. Bcl-2, Bcl-xl and Bcl-w are the anti-apoptotic genes; they function as the 
inhibitor of mitochondrial permeability. A central checkpoint of apoptosis is the 
activation of Caspase-9 by mitochondria. The BH4 domain of Bcl-2 and Bcl-XL can 
bind to the C terminal part of Apaf-1, thus inhibiting the association of Caspase-9 
with Apaf-1 (Hu et al. 1998). 
 
1.7. Caspases 
The specific feature of apoptosis is the cystein proteolytic enzymes called caspases; 
the C part of caspase refers to the cystein protease whereas the aspase refers to the 
specific location where the enzyme will cleave (Kumar et al. 2010). Although this is 
the case in apoptosis, Caspases should be removed from the definition of apoptosis 
as the protein is not universal for all the apoptosis process. Fourteen caspases have 
been identified so far, they all share some of their properties. All are aspartate-
specific cystein protease, have conservative pentapeptide active site "QACXG" and 
their precursors are zymogens known as pro-caspases (Fan et al.2005).The N 
terminal of the procaspases has a structure responsible for caspase activation 
(Hermine et al.2005), has two DED(death effector domain) which make the N 
terminal a critical site recruiting the death domain.  
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Figure1.4: Involvement of procaspase-8 in death-receptor signalling. (A) Procaspase-8 is 
recruited to the CD95 or TRAIL DISC through the adaptor protein FADD. 
According to Fan et al. (2005), Caspases have been divided into three subfamilies, 
Subfamily I, II and III. Subfamily I consist of Caspase-2, 8, 9 and 10, they are known 
to be the activator of apoptosis and are capable of autolytic activation. Subfamily II 
consist of caspase-3, 6 and 7, they play a role in execution of apoptosis and require 
activation by initiating caspase cleavage (Ricci and El-Deiry) and subfamily III made 
up of caspase-1, 4, 5,11,12,13 and 14 which function to mediate inflammation. 
According to Wang et al. (1998), caspase 1 and 11 play a role in the cytokine 
processing and function of other caspases of the subfamily are unknown (Budihardjo 
et al. 1999). Caspases called interleukin-1 beta-converting enzyme (ICE) proteases, 
family of cysteine proteins that act as effector of the mammalian cell death pathway 
are the first caspases initially discovered as a cytokine-processing enzyme 
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(Budihardjo et al.1999). The structural changes of a cell as a result of apoptosis are 
due to activation of ICE. 
At times apoptosis processes occurs faster than phagocytic cells can cope with. 
Because of this, apoptotic cells are released to neighboring cells resulting in 
Necrosis (Trump et al. 2001). Another reason for a switch from apoptosis to necrosis 
can occur when the proteins involved in apoptosis are removed or inhibited (Golstein 
and Kroemer, 2006). Because of ATP is required for the optimal activation of 
caspase, the depletion of ATP is one of the factors that lead to necrosis.  
 
1.8. Necrosis 
Necrosis comes from the Greek word ‘necros’ meaning death. Walker et al. (1988) 
defined necrosis as the cell death that occurs due to unfavorable environmental 
conditions or genetically encoded insults. In 2006, Golstein and Kroemer defined 
Necrosis as a lytic destruction of individual or group of cells and have been 
considered to be uncontrolled. The dominated concept in necrosis has been 
specified as a chaotic breakdown of cell under intolerable conditions (Syntichaki and 
Tavernarakis, 2002).The loss of cells ability to regulate homeostasis is the beginning 
of necrosis, this result in water retention and excretion of ions. This mode of cell 
death results as the consequences of internal stress such as heat, osmotic shock, 
freeze thawing and high concentration of hydrogen peroxide as well as the 
physiological conditions such as hypoxia, ischemia, hypoglycemia, toxin exposure, 
exposure to ROS metabolites and nutrient deprivation (Nicotera et al. 1999). 
According to Mayhew et al. (1999) renewal of small intestine is a physiological 
evidence that necrosis can occur as part of the normal cell loss (Murdoch et 
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al.1999). It often results in rupture of the plasma membrane and the organelle 
breakdown (Majino and Joris, 1995) which may promote the tumour progression 
through degenerative proliferation and invasion. Necrosis can be characterized by 
mitochondrial dysfunction such as production of ROS (reactive oxygen species) by 
mitochondria, swelling of mitochondria(oncosis), ATP depletion, failure of Ca2+ 
homeostasis, perinuclear clustering of organelles, activation of calpains and 
cathepsin, lysosomal rupture as well as plasma membrane ruptures (Dimitri et al, 
2007). 
 
Figure 1.5. A diagram showing the biochemical and morphological characteristics of 
Apoptosis and Necrosis. 
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 Apoptosis is characterized by cell shrinkage, nuclear condensation, membrane 
blebbing and cellular & breakage of DNA strands  whereas Necrosis is characterised 
by mitochondrial dysfunction, swelling of mitochondria (oncosis), ATP depletion, 
failure of Ca2+ homeostasis, perinuclear clustering of organelles, lysosomal rupture 
as well as plasma membrane ruptures. 
 
 Dengenhart et al. (2006) believe that the inhibition of mitochondrial membrane 
permeability caused by the down-regulation of pro-apoptotic protein or the over 
expression of anti-apoptotic proteins shift the cell death from apoptosis to necrosis. 
There has been a debate between researchers on whether necrosis contributes to 
normal cell loss. Upon researches done, it was discovered that the biochemical and 
morphological characteristics of necrosis and apoptosis can be found in the same 
cell. The findings revealed necrosis contributes to normal cell loss, although it is 
believed necrosis only takes over after the genetic mutation that stops apoptosis 
before the activation of caspases. A study by Chauhan et al. (1999) discovered a 
morphological shift from apoptosis to necrosis in the interdigital of a mouse when 
apoptosis or caspase independent cell death is inhibited. Necrosis does not only 
occur due to pathological stimulus but also due to physiological events.  Mutation or 
inhibition of caspase can signal the damaged cells to go through necrosis.  
The two mode of cell death discussed occur as results of the cell damage that was 
impossible to repair, tumor suppressor genes play a huge role in identifying the 
mutation in the cell and arresting the cell proliferation to ensure the integrity of the 
cell is maintained. 
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1.9. Tumor Suppressor genes 
Carcinogenesis occurs as a result of the loss of tumor suppressor genes and the 
gain of oncogene (Sigal and Rotter, 2000). Tumor suppressor gene has been 
defined by Sulina and Balan (2012), as genes whose products can transform the 
normal cells to tumor cell and whose loss of function can contribute to malignancy. 
To date there are more than 30 tumor suppressor genes identified. p53 and 
Retinoblastoma are the two well-studied tumor suppressor genes in cancer research. 
 
1.9.1. Tp53 
 
TP53 (tumors protein 53) is the synonym of p53; it is a 393-residue polypeptide and 
contains five functional domains. The N terminal domain involved in transcriptional 
activation, a proline rich domain that Mdm2 binds to, the central core domain that 
involves in DNA binding, the oligomerization domain that involves in p53 
tetramerization and lastly the basic C-terminal domain that can inhibit sequence-
specific DNA binding by the core domain (George, 2011). Cell cycle check point was 
first understood through King and Cidlowski, 1998 when there was no thorough 
checks on the apoptosis and proliferation of the mice’s cells. In response to DNA 
damages, p53 stop the transcription at the G1-S phase to allow repair processes to 
restore cell integrity (Kuerbits, 1992). p53 does this by its transcriptional activation 
functions and binds to the transcriptional factor called E2F which prevent E2F from 
binding to the promoters of proto-oncogene. p53 again regulate cell cycle, this is 
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done by the transcription factor GADD45 (Growth Arrest and DNA Damage), that 
binds to PCNA (Proliferating Cell Nuclear Antigen) and stimulates excision repair.  
 
p53 gene was discovered in 1979 by Levine et al, (1979), it was first thought to be an 
oncogene because it portrayed an ability to promote growth in the cell lysate of 
simian virus (SV40) (DeLeo et al, 1979; Melero et al, 1979). This is because p53 
made a stable complex with SV40 large T-antigen which has an oncogene potential.  
It was later discovered by DeLeo et al, (1979) and Lane & Crawford, (1979) that the 
p53 discovered initially was a mutant gene found in variety of human cancer cells. 
George, (2011) stipulated in one his articles about p53 that the cancer related to p53 
are more aggressive and have high degree of fatalities. E. Vogelstein and White, 
(2010) confirmed p53 to be tumor suppressor gene after the study on colon cancer. 
 
According to Hollstein et al. (1991), fifty percent of human cancer cells have the p53 
that lost its main function. p53 p53 is located on chromosome 17 and composed of 
11 exons. It plays a role in the negative regulator of a human cancer. According to 
Field, (1995), Function of p53 gene can be converted to the oncogene due to 
mutation on its gene. Crawford, (1984) found that the mutated p53 has long half-life 
as compared to the wild type, because of this the mutated p53 provide a resistance 
of tumor to anticancer drugs and it is mediated by hetero-oligomerization through the 
oligomerization domain (Rovinski and Benchimol, 1988). p53 had been known as the 
solitary gene, the gene homologs p73 and p63 have been discovered by Kaghad et 
al. (1997) and Yang et al. (1998) respectively. The collaborative study of Yang and 
Kaghad (1998) revealed the two homologs of p53 act as a nuclear sequence-specific 
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transcription factor which transactivate the overlapping set of p53 and has the ability 
to induce cell cycle arrest ( Krysko et al. 2008). According to Clarke et al. (1993) and 
Lowe et al.(1993), p53 does not carry out its function in every form of apoptosis. It is 
only the activator of cell death. 
Upon the DNA damage, the p53 mediated pathway is activated. The tumor 
suppressor gene binds to the damages DNA and causes the cell division cycle arrest 
to stop the proliferation allowing the repair process to take over to maintain cell 
function. When the process is complete and the DNA is repaired, the proliferation 
proceeds. If the repair is impossible, the role of p53 comes to play which leads to 
apoptosis (Bose and Ghosh, 2007). p53 can negatively be regulated by Mdm2; a 
protein that binds to the p53 and prevents p53 to carry its function. The expression of 
Mdm2 is activated by p53, therefore if p53 increases so does Mdm2. The protein 
kinase activated upon DNA damage phosphorylates p53 and reduce the affinity of 
Mdm2 on p53. When the p53 is phosphorylated, it does not matter the quantity of 
Mdm2, it will not be negatively affected by Mdm2 and thus continue its function. 
1.9.2 Retinoblastoma pRb 
Retinoblastoma is the tumors suppressor genes and its protein precursor pRb arrest 
the cell cycle on the S-phase to allow cell repair (Sunila and Balan, 2012). The 
existence of tumor suppressor genes was reported by Boveri (1914) and the pRb 
was the first TSG identified by Friend et al. (1986), Fung et al. (1987) and Lee et al. 
(1987). The gene is located on the 13q 14 chromosome, about 200 kb large and has 
27 exons. pRb is a regulator of G1 phase and possess 16 sites of cdk 
phosphorylation. pRb is found in the G1 phase in a hypophosphrylated state and 
tightly bound to the E2F transcriptional factor. Upon phosphorylation by the Cdk 
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complex breaking the pRb-EF2 interaction. E2F becomes transcriptionally active to 
progress from G1 to S phase (Johnson et al.1993). 
 
1.10 Aim of the study 
Based on the literature and our understanding of cancer progression, the aim of this 
study was to evaluate the methanolic extracts of Sutherlandia Frutescens on cervical 
cancer cell lines. 
Objectives 
a) To use MTT and Xcillegence to check if extracts of Sutherlandia Frutescens 
can induce apoptosis in cervical cancer cell line 
b) To check the expression levels of p53, bax, bcl2, RBBP6, Mdm2, Rb and 
caspases 
c) To identify the type of cell death induced by Sutherlandia Frutescens using 
Flow cytometer. 
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2. Materials and Methods 
 
2.1 Cervical cancer cell lines 
SiHa was used in this study to evaluate the cytotoxicity effects of Sutherlandia 
Frutescens extracts. SiHa cell is the cervix cell line that causes grade II squamous 
cell carcinoma and believed to be discovered from a 55 years old Asian woman. 
 
2.2. Plant extraction 
Plant material (leaves) was dried for 3days at 50°C, powdered and autoclaved. A 
solution of 100mg/ml in 70% methanol was prepared and allowed to extract for 
24hours.The supernatant was removed and filtered through a 0.2µm filter 
(Chinkwo.2005), Methanol was then evaporated. The extracted material was 
suspended in 10% DMSO (dimethyl sulfuroxide) to make an initial concentration of 
5.0mg/ml of stock solution. 
 
 
2.3 Cell culture 
The cervical cancer cell (SiHa cell line) was cultured in RPMI 1640 medium 
supplement with 10% Foetal Bovine Serum (FBS), 1% of 2Mm L-glutamine 
(Keawpradub et al. 1999), 1% penicillin/streptomycin/fungizone cocktail and 0.5% 
gentamycin. The culture was grown at 37°C in a humidified atmosphere of 5 %( v/v) 
CO2 in air (Chinkwo. 2005). 
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2.4 MTT assay 
The MTT {3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide} assay 
measure the cells ability to survive in unfavourable conditions, it is a yellow substrate 
that produce a dark insoluble formazan in the mitochondria. The formation of 
formazan is due to the cleavage of tetrazolium ring by dehydrogenase enzymes of 
live cells. The formazan requires an organic solvent to be solubilised; the solubilised 
formazan can then be measured on a spectrophotometer (Mosmann, 1983). Since 
MTT can only be reduced in metabolically active cells, it has been used to determine 
the amount of viable cells versus the dead ones. For this study, the assay was used 
to check the survival of the cells when subjected to the anti-tumor agent.  Cells were 
plated into ninety six well tissue culture plates and incubated overnight. Cells were 
then treated with different concentrations (50 µg/ml, 100µg/ml, 150µg/ml and 
200µg/ml) of the herbal extract. A non-treatment control and a blank were included. 
Cells incubated overnight, followed by addition of MTT and further incubated. The 
formazan crystal formed was dissolved by DMSO and the plate was read using a 
Bio-Rad Microplate reader at an absorbance of 570 nm. 
 
Percentage Cell Viability was calculated as follows: 
% Cell viability = Absorbance of treated cells – Absorbance of blank     X 100 
                            Absorbance of untreated cells – Absorbance of blank 
 
 2.5 Flow cytometry 
The flow cytometer is highly sophisticated equipment used to analyse individual cells 
in heterogeneous populations. It allows thousands of cells to pass through a light 
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beam every second (Potten and Wilson 2004), and then it can distinguish these cells 
based on size and health (viable or dead) amongst other parameters. This technique 
was employed following the MTT assay to investigate whether the herbal extract is 
inducing cytotoxicity to the cells by either necrosis or apoptosis. Annexin V and 
propidium iodide measured the number of cells undergoing apoptosis, necrosis as 
well as the viable cells. Annexin V has high calcium dependent affinity to 
phosphatidylserine residues; these residues are normally embedded in the 
cytoplasmic plasma membrane in healthy cells but move to the surface of the cells 
during apoptosis. Therefore, Annexin V can bind to these residues acting as a probe 
for flow cytometric analysis of cells that are undergoing apoptosis. Propidium iodide, 
a reagent which is used in tandem with Annexin V, is a non-cell permeable DNA dye 
which will stain cells undergoing necrosis. This will then distinguish between 
apoptotic and necrotic cells. 
 
Cells were incubated overnight then treated with the plant extract at a concentration 
that induced ~50% cell death and then further incubated overnight. Cells were 
treated with Annexin V-FITC Apoptosis Detection Kit according to manufacturer’s 
specifications. The cells were then analysed by flow cytometry.  
 2.6 Phytochemical screening 
Following the extraction of crude extract using various solvents from the two plants, 
phytochemical screening was conducted. Phytochemical screening was carried out 
to identify Sutherlandia Frutescens’s phytochemical constituents i.e. if there is 
presence of alkaloids, flavonoids, tannins, glycosides, phytosterols etc. (Tiwari et al. 
31 | Ms Rakoma M.A MSc Life Science 
 
2011). The method was done at the University of Fort Hare using the Time of flight 
Mass spectrophotometer. 
 
 2.7 Caspase 3/7 Assay 
Furthermore Caspase 3/7 assay was employed to determine if cell death was 
induced by caspase dependent. The cells were pipetted into the 96-well plate and 
incubated overnight to allow cell to attach on the bottom of the plate. CaspaseGlo 
substrate in buffer was added on to the 50µl cultured cells mixed and incubated for 
an hour at 37°C in the dark. The luciferase activity was then read using the 
Glomax®-96 microplate luminometer. 
 
 2.8 ATP Assay 
Adenosine Triphosphate is used to measure the biological activity of the cells and 
the amount of ATP is directly proportional to the amount of live cells. The 50µl 
CellTiter substrate in buffer was added on to the cells that were incubated overnight 
in the 96-well plate.  Cells were then mixed and incubated for an hour at 37°C in the 
dark. The ATP level was quantified using GLOMAX (Promega, USA). 
 
 2.9 Statistical Analysis 
Two-tailed student t-test was done to compare the significance difference between 
treated and untreated cancer cells. The probability value (p>0.05) of less than 0.05 
indicates a significance difference of the treated cancer cells with respect to the 
untreated cancer cells. 
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CHAPTER 3 
 
Results 
Introduction 
The cytotoxicity of Sutherlandia frustescens has been investigated on other types of 
cervical carcinoma but nothing was found on SiHa. The plant has been used for 
many years to cure various illnesses such as stomach ache, fever, internal cancer 
and diabetes. The plant is also called kankerbos/cancer bush due to the confidence 
the xhosas,zulu,sotho and cape Dutch have on the ant-cancer activity of the plant 
but the mode of action on cervical cancer is not well researched. Due to the 
cytotoxicity effect of the plant on SiHa and the mode of action on cervical cancer not 
well researched, the study was conducted to evaluate the cytotoxicity of the plant as 
well as the mode of action on SiHa and HeLa. 
3.1. Phytochemical compounds found from Methanol and Aqueous 
extracted S.F after Mass spectrophotometry  
Table 3.1. 
(A)  Methanolic Extract 
Compound Structure Solvent and 
Cancer type for 
anti-proliferative 
effect 
Reference 
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(+)-3-
carene 
C10H16 
 
 
 
 
 
DMS0 Solvent 
Breast, colon, 
lung and glioma 
cancer 
Mahahpara and 
Washat 
columbami
ne 
C15H20O2 
 
 
 
 
 
 
Ethanol 
Pheripheral 
blood 
mononuclear 
blood 
 
human 
osteosarcoma 
U2OS  
 
EL-Wahab et al, 
2013 
 
 
 
Bao et al. 2012  
 
(E)-ß-
ocimene 
C10H16 
 
 Colon,glioblasto
ma, human 
adenocarcinoma 
and 
hepatocellular 
carcinoma 
De Oliveira et 
al.2015 
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(+)-ß-
pinene 
C10H16 
 
 
 
Ovarian and 
Hepatocellular 
carcinoma 
 
DMSO 
Lung,glioma,brea
st and colon 
cancer 
Wang et al, 
2012 
 
 
Wajahaka Shah 
2014 
 
(+)-a-
pinene 
C10H16 
 
 
 
Ovarian and 
Hepatocellular 
carcinoma 
 
DMSO 
Lung,glioma,brea
st and colon 
cancer 
Wang et al, 
2012 and Chen 
et al, 2015 
 
Wajahaka Shah 
2014 
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15-cis-
phytoene 
C15H22O2 
 
 
 
Reduce risk of 
lung and 
epithelial cancers 
on human 
Pharmacodyna
mic basis of 
herbal 
medicine, 
second edition 
by Manuchair 
Ebadi 
 
(B) Aqueous Extract 
Compound Structure Cancer type for 
anti-proliferative 
Reference 
 
 
 
zerumbone 
C15H26O1 
  
HeLa and HepG2 Sakinah et 
al.2007 
delphinidin 3-O-
sophoroside 
C20H19O5 
 
 Murine 
melanoma,Ovarian 
and Cervical 
cancer 
Diaconeasa 
et al.2015 
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dihydrohomopteroate 
C16H25N5O6 
 
 
  
 
 
3.2The cytotoxic effect of Sutherlandia extract on SiHa 
MTT assay was employed to determine the cell viability of SiHa using IC50 the 
concentration at which 50% of cell respond positively to the extract. Upon treatment 
with varying concentrations (50,100,150 and 200µg/ml), the cell viability Vs extract 
concentration was plotted allowing the quantification of changes in the cell 
proliferation.                                                                                                                                                      
Cells were treated with varying concentrations of the methanolic extract and 
incubated for 24 hours. Following the incubation period, MTT reagent was added into 
each well including the media only which serves as blank for comparable purpose. 
Untreated cells were used as a 100% cell viability and 0.5µM Taxol as a positive 
control. Dehydrogenase enzymes present in the live cells are responsible for the 
conversation of MTT to formazan, this is done when dehydrogenase cleaves 
tetrazolium ring. DMSO was then added after 4 hours of incubation to solubilize the 
formazan formed by metabolically active cells. The results were read by 
spectrophotometer at wavelength of 570nm and a wavelength reference of 600nm. 
Following treatment of SiHa, there was a reduction in cell proliferation for 50µg/ml, 
100µg/ml and 200µg/ml with cell viability of 52%, 53% and 56% respectively. The 
concentration 150µg/ml exhibited the cell viability of 263%.This could be due to the 
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enzymatic reaction from MTT with no decrease in the number of cells that lead to the 
conclusion that the cells are alive whereas they are slowly dying. The results are 
depicted on the below graph Figure 1.The cell death statistical significance was 
calculated using two-tailed t-test at a 95% confidence interval. When treated-cells 
were compared statistically with the untreated, the P value of 0.05 was obtained on 
cells treated with 50µg/ml of the plant. The P value of greater than 0.05 was obtained 
when the standard deviation of the treated was compared with the standard 
deviation of the untreated cells. The SD±Error showed cell death of 0.07±0.070 of 
untreated cells as compared to 0.23±0.52 and the Taxol-treated showed a 
0.03±0.37. The cells treated with 100µg/ml and 200µg/ml concentrations showed a 
cell death of 0.05±0.50 and 0.40±0.14 respectively. The cells treated with 150µg/ml 
showed cell death of 0.23±0.11. 
 
  Figure 3.1: The cytotoxic effect of methanol extract of S.F on SiHa. Cells were plated and 
incubated for 24 hours to allow the cells onto the wells. Cells treated with varying 
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concentrations and incubated for 24hrs. MTT reagent was added followed by addition of 
0.1% DMSO to solubilize the formazan. Absorbance was read which was used to calculate 
the cell viability.  
 
3.3The Effects of Sutherlandia Frutescens methanolic extract on the cell 
growth of SiHa cell line. 
Growth of SiHa cells was determined by Xcillegence, a new system tool to measure 
the cell activity in a real time. Cells were seeded into the 96 well plates and treated 
with varying concentrations of methanolic extract of S.F. DMSO and Taxol were 
used as a vehicle control and reference compound respectively to compare the level 
of cytotoxicity of the extract.  
Cells were seeded in 96 well plates and incubated for 24 hours. The SiHa cells were 
then treated with plant concentrations used in MTT assay. Continuous changes in 
the impedance were measured and presented as cell index (CI), a dimensionless 
parameter reflecting the biological statue of monitored cells including cell number, 
cell viability, cell morphology and cell adhesion. The cell index value denotes a 
quantitative measure of proliferative status of cells in real time.  Results are depicted 
in Figure 2 where the 100µg/ml is represented by the lime graph, Untreated, DMSO 
and 0.5µM Taxol are represented by pink, blue and choral respectively. The 50µg/ml 
was depicted by the red graph; 150µg/ml and 200µg/ml were represented by the 
purple and turquoise respectively. 
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The untreated cells continued to grow as expected, cell density kept decreasing after 
77 hours of treatment with 0.1% DMSO. DMSO has been documented to cause 
cancerous cells to become benign and has also been shown to slow the 
development of cancer; this has been shown on DMSO-treated cells. The cell 
proliferation was normal afore treatment. Upon treatment with 50µg/ml, cells 
decreased to less than 1.0 cell index where it stayed stable to 88 hours. The 
Microplate has electrodes at the bottom which detect the cell viability, as more cells 
are detaching the cell index decreases. This is an indication that indeed the plant 
has a cytotoxic effect on the SiHa cell line. Taxol as a positive control has a 
decrease in the impedance, this could have been because the cells slowly detaching 
thus reducing the cell density. The effect of paclitaxel (Taxol) on various cancers has 
been researched and evidence showed it disrupts microtubules dynamics by 
promoting tubulin polymerization and stability which leads to cell cycle arrest at the 
G/M phase. 
Keys 
     Untreated       100µg/ml Methanol extracts    
 0.1%DMSO     150µg/ml Methanol extracts    
 0.5µMTaxol      200µg/ml Methanol extract    
  50µg/ml Methanol extract       
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Figure 3.2: Xcelligence analysis of the effect of methanol extract on the cell growth on SiHa 
in real time. Cells were seeded in 96 well plates and incubated for 24 hours. The SiHa cells 
were then treated with the increasing concentration 50µg/ml, 100µg/ml, 150µg/ml and 
200µg/ml of methanol extract represented by the red, lime, purple and turquoise graphs. 
Untreated, DMSO and 0.5µM Taxol are represented by pink, blue and choral respectively. 
 
3.4. The Effect of Sutherlandia Frutescens methanolic extract on the 
Casapase activity of SiHa Cell lines. 
A positive result in apoptosis assay is not a confirmation that the drug or anti-cancer 
agent has an apoptotic effect on the cancer cells, Two or more assay need to be 
performed as necrosis and apoptosis share some of the features. The morphological 
changes resulting in apoptosis is caused by the caspases which either activate or 
deactivate specific substrate along the way. Proteolytic cleavage of effector 
caspases is an indication of their activation, this does nothing for initiation. Caspases 
3 activation plays a role in initiation of cellular events during early apoptosis process. 
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Caspases has been identified as a major contribution to the execution of apoptosis. 
Both caspase 3 and 7 are responsible for the downstream cleavage of substrate 
such as PARP. During apoptosis, caspase 7 is activated by upstream caspases 
through proteolytic processing at Asp23, Asp198 and Asp206, thereby producing the 
mature subunits. Because caspase activation is the fundamental part in the apoptotic 
pathway, caspase activity was employed to determine if the mode of action is 
caspase dependent. 
 
The caspase activity is measured by the Luminescent which is dependent on the 
luciferase formulated to generate the glow type luminescent. The results depicted on 
Figure 3 shows that there was a slightly less difference between the caspase activity 
in the untreated and IC50. This may be because apoptosis as the normal 
programmed cell death try to balance the cells in the living cells. 
 
Following the MTT assay and flow cytometry assay which indicated that the SiHa 
cells dying via apoptosis, the caspase activity was employed to verify results found 
on the above assays. There was less caspase activity as expected because the cells 
were not subjected to any cytotoxic agent. The caspase activity observed in 
untreated cell could be due to the normal programmed cells death, the same 
observation has been documented in lung cancer. This is believed to be the reason 
for reduction to treatment sensitivity. Literature reported this kind of cell death as 
senescence, a programmed cell death that limits tumour development.  
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The low levels caspase indicates a reduced apoptosis and carcinogenesis. More 
caspase activity was observed in cells treated with Taxol. Taxol is used as the anti-
tumor agent for various cancers and it is documented to induce apoptosis through 
caspase and without caspase. Our results shows cell death was via caspase-
dependent apoptosis. The 50µg/ml as found from MTT to induce 52% of the cell 
death has been used in the caspase activity and the observation on figure 3.3 
indicate there was a loss of mitochondrial membrane. The pro-apoptotic proteins 
were then released that trigger the caspase cascade resulting in apoptosis. 
 
 
Figure 3.3: The Caspase activity graph depicting the results after the cells were treated with 
0.5µM Taxol and IC50 from MTT. Caspase 3/7 reagent was added into the cells for cell lysis 
to expose caspase so luciferase which cleave the caspases resulting in a glow type 
luminescent. The fluorescence is proportional to the caspase activity. 
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3.5 The Effect of methanolic S.F extract on cell cycle and apoptosis  
The IC50 found from MTT assay is expected to have the cytotoxic effect on the SiHa 
cells via apoptosis by arresting the cell cycle before mitosis. To achieve this, the 
cells were treated with IC50, incubated for 24 hours and was exposed to FITC 
Annexin V and then Propidium iodide staining. Annexin V was used to bind to the 
phosphatidylserine serine to measure the early apoptosis as during this time, 
membrane asymmetry is lost and phosphatidylserine translocate to the leaflet. To 
distinguish between early apoptosis and late/necrosis, PI was used. PI does not 
stain the cells in early apoptosis because at this time the plasma membrane is still 
intact. As the cells move to the late apoptosis, the integrity of plasma membrane 
decreases thus allowing the PI to pass through the membrane and intercalate into 
the nucleic acid showing a red fluorescence. 
 
The effect of S.F treated cells on cell cycle was measured by flow cytometry. Flow 
cytometry analysis revealed an increase in the apoptotic fraction with an increase in 
untreated cells G0/G1 in untreated (49%) and Taxol (85%) as compared to the IC50 
(40%).High volume of Taxol and IC50 treated cells were residing in the S phase with 
39% and 40% respectively as compared to 9% in the untreated cells. Cell cycle 
arrest in the G0/G1 phase of the positive control and treated cells as well as in the 
G2 phase was observed. The observation was as a result of a high percentage of 
cells in S phase as compared to the G2/M Phase. Cells normally progress to the 
G2/M phase and because only 27% of treated cells proceeded to the gap 2 phase, 
apoptosis occurred. 
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Figure 3.4(A): Flow Cytometry analysis of SiHa cell subjected to plant extract and Taxol. 
Cells were incubated for 24 hours to attach to the wells. Cells were then treated with IC50 and 
0.5µM Taxol as a positive control and stained with Annexin V followed by Propidium 
Iodide. Cells were then analyzed by flow cytometry prior to incubation at room temperature 
for 15min 
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Figure 3.4(B): Represents the Flow Cytometry analysis of SiHa cell subjected to plant 
extract and Taxol, cells were incubated for 24 hours to attach to the wells. Cells were the 
treated with IC50 and 0.5µM taxol as a positive control and stained with PI and were then 
analyzed by flow cytometry. 
 
Cell cycle is not sufficient to prove apoptosis, cell cycle would reveal the DNA 
fragmentation but this can occur in necrosis as well. To prove apoptosis, the effect of 
methanol extract on SiHa cells was evaluated by Annexin V/PI staining through flow 
cytometry. When cells are doubled stained with Annexin V/PI the different population 
of cells are observed. The cells that are not stained with either Annexin V or PI are 
viable cells and are shown in quadrant 3, cells stained with Annexin V but not PI are 
dying by apoptosis and resides in quadrant 4.The cells that are not stained with both 
the dyes are nonviable cells in the late apoptosis residing in quadrant 2 while cells 
scattered in quadrant 1 are necrotic cells.  
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On observing the results on Figure 3.5 B for S.F-treated cells, 20% of cells stained 
positive for externalized phosphatidylserine residues indicating that the extract 
induced 20% apoptosis in SiHa cells whilst 74% remained alive. Positive control 
Taxol-treated cells demonstrated 12% of phosphatidylserine externalization 
indicating the cells were dying by apoptosis and 79% of the cells remained alive. 
Comparing the externalization of S.F-treated cell and that of positive control, the low 
count of apoptotic cells in S.F-treated cells may be because of the possible error in 
the initial low cell count resulted prior staining when supernatant was removed. 
Despite the possibility of error mentioned, it is clear S.F extract induces apoptosis in 
SiHa cells as more cells were residing in Q2 and Q3 indicating apoptosis. The 
untreated 14% of cells stained positive for externalized phosphotidylserine residues 
whilst 72% remained alive. As previously mentioned, cells die naturally to balance 
the homeostasis in the cell cycle and this was indicated by less than 12 % of cell 
death by apoptosis. 
 
3.6. The effect of S.F compounds (Canavanine, GABA and Pinitol) on 
SiHa Cell line 
Although number of literature suggests that GABA has no other functions other than 
being the neurotransmitter, there was a significant cell death when SiHa cells were 
exposed to GABA. The concentration used was 100µM, 300µM and 500µM which 
resulted in 51%, 53% and 48% cell death respectively. The results shows cell death 
decreases after 300µM.Although the results contradicts with the study by Yue-Hui et 
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al, (2012) that shows GABA increases proliferation of HepG2 cells in a dose-
dependent manner, it  is supported by Chan-Ho oh and Suk-Heung Oh (2004) that 
proved GABA significantly induces apoptosis on the L1210(Leukemia) cells.  
Canavanine is believed to be the major constituents in the S.F plant and an anti-
tumor agent in various cancer cells has been proven once more in this study as the 
compound induced cell death by 54% for both 1000µM and 1500µM and slightly less 
cell death of 53% when SiHa cells were treated with 2500µM. The results shows cell 
death decreases after 2500µM concentration of the compound. The concentration 
may be too high for the cells that they could not survive. The study did not go further 
to analyze the mode of action of the cell death which needs to be done as the follow 
up to clearly understand the decrease in cell death after the specific concentration of 
the compound. 
The observation from GABA and Canavanine is also seen in Pinitol treated cells 
where a slight difference in cell death was observed. The cells were treated with 
three various concentrations 30µM, 90µM and 120µM and the concentrations 
induces 53%, 50% and 44% cell death respectively. The findings indicate that the 
cell death decreases as concentration decreases. 
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Figure 3.5: The cytotoxic effect of methanol extract of Canavanine on SiHa. Cells were 
plated and incubated for 24 hours to allow the cells onto the wells. Cells treated with varying 
concentrations and incubated for 24hrs. MTT reagent was added followed by addition of 
0.1% DMSO to solubilize the formazan. Absorbance was read which was used to calculate 
the cell viability 
 
 
Figure 3.6: The cytotoxic effect of methanol extract of GABA on SiHa. Cells were plated 
and incubated for 24 hours to allow the cells onto the wells. Cells treated with varying 
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concentrations and incubated for 24hrs. MTT reagent was added followed by addition of 
0.1% DMSO to solubilize the formazan. Absorbance was read which was used to calculate 
the cell viability 
 
Figure 3.7: The cytotoxic effect of methanol extract of Pinitol on SiHa. Cells were plated and 
incubated for 24 hours to allow the cells onto the wells. Cells treated with varying 
concentrations and incubated for 24hrs. MTT reagent was added followed by addition of 
0.1% DMSO to solubilize the formazan. Absorbance was read which was used to calculate 
the cell viability. 
3.7 The effect of Sutherlandia Frutescens methanolic extract on the ATP 
levels in SiHa cells. 
Adenosine Triphosphate is a biological indicator of metabolically active cells which is 
quantified by detecting luminescence. The assay determines the number of treated 
cells in comparison with untreated cells. After the SiHa cells were treated with the 
three compounds, IC50, Taxol as the positive control, the cells were subjected to 
CellTiter-GloTM substrate in buffer to determine the amount of ATP in the SiHa 
treated cells. Figure 8 shows a significant higher ATP levels in S.F treated cells with 
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more than 100000 luminescence followed by GABA, Canavanine and pinitol with 
60000, 40000 and 10000 luminescence respectively. In this study we also observed 
increase in mitochondrial activity within 8 hours of treatment with methanolic extract 
followed by a drop immediately after which suggested disintegration of mitochondria 
and loss of cell function Because the ATP level is proportional to the amount of 
viable cells, the results shows there are more viable S.F treated cells at first and 
upon treatment, the was a loss of mitochondria and the findings is consistent with the 
MTT assay. Pinitol showed a significant decrease in ATP and thus cell viability, this 
correlate with the pinitol MTT results while Canavanine and GABA showed a 
decreased in ATP as compared to IC50. The results contradict with that of Skerman et 
al, (2011) that showed S.F extract decreases the level of ATP in Esophageal cancer 
cell line. 
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Figure 3.8: The ATP level of the cells treated with IC50, Canavanine, Pinitol and GABA are 
depicted on the graph after the luminescence was quantified. 
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Chapter 4 
Discussion 
Medical plants have been used for decades as a source of health concoctions for 
various ailments such as arthritis, stomach ache and cancer. It is widely known as 
the cancer bush as it is believed to cure cancer. Traditional healers boiled the plants 
to extract essential compound, which was given to patient directly to drink. The 
traditional healers and most Africans are still using the same methods, Smoking the 
plants or steaming with the plants was alternative methods. The methods were not 
effective as number of compounds present in the plant were not efficiently extracted 
and that is believed to be the drawback of the plant and the possible reason the 
chemical constituents or the mode of action of the plants is not clearly understood 
There were incidences where patients were believed to be cured of various diseases 
(Van Wyk and Albrecht, 2008).These claims by traditional healers risen the edge for 
the scientists to research the traditional medicines in the aim of finding the efficient 
and cheap drugs with less side effects. 
 
Over the years various medical plants have been research for the purpose of drug 
discovery and among the plants Sutherlandia Frutescens which is mostly found in 
the dry parts of South Africa was among the researched. The phytochemical study 
done on the plant revealed various compounds that are believed by scientist to be 
the reason the plants is used in various ailments and was then named cancer bush. 
The major component being Canavanine Pinitol and GABA where canavanine is 
believed to be the leading compound contributing to curing cancer. 
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To establish whether the plants exhibited the inhibitory effect on the cancer cell line, 
the MTT assay was used. The results of the MTT assay was the IC50, the 
concentrations at which 50% of the cancer cells positively reacted to the extract. This 
is done when MTT reagent is reduced by metabolically active cells resulting in intra-
cellular formazan which is then solubilized by DMSO and quantified using a 
spectrophotometer. The results showed the significant decrease in cell density when 
the SiHa cells were subjected to Sutherlandia Frutescens extract. The untreated 
cells were included as 100% cell viability, Taxol as the positive control and DMSO as 
the vehicle control for comparable purpose. The 50ug/ml showed 49% cell viability 
whereas 100 and 200µg/ml showed 38 and 37 cell viability respectively. ATP assay 
correlate with the MTT assay as it showed an increased ATP level in extract treated 
cells as compared to untreated Taxol and the compounds. Pinitol showed a low ATP 
level. 
 
The MTT result indicates that the three extract concentrations induce cell death in 
SiHa cells therefore the 50ug/ml was concluded to be the IC50 resulted from the 
assay as the cell density decreased significantly as compared to the two 
concentrations (50µg/ml and 200µg/ml).MTT assay was also done on canavanine, 
pinitol and GABA, the results depicted in Figure 5, 6 and 7 shows the compounds 
have a cytotoxic effect on the SiHa cells. The IC50 was 1000µM, 30µM and 100µM 
for canavanine, pinitol and GABA respectively with 50% cell cytotoxicity. GABA was 
first believed to only have function as the neurotransmitter but an enormous number 
of researches are being done on the GABA as the anti-cancer compound. The cell 
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density decreased with the concentration above the IC50 of the three compounds, 
this may be because the high concentrations were being harsh to the cells thus 
killing normal cells. Further research needs to be done to determine the mode of 
action of the compounds on the SiHa cell line. 
 
 Looking at the previous research done of the plant as the anti-cancer activity, 
Chinkwo, 2005 resulted in similar findings when cervical carcinoma and Chinese 
Hamster Ovary cancer cell lines were treated with aqueous extraction of 
Sutherlandia Frutescens. The findings on the cytotoxic of the plant indicates the 
plant has a potential in the drug discovery as it showed not to kill normal cells but 
cancer cells only. Apoptosis has been defined as the programmed cell death that 
occurs normally in the cell for replacement tissue remodeling and removal of 
damaged cells (Kerr et al, 1972 and Elmore，2007).Apoptosis is the preferred 
method of cell death as the phygocytotic cells are engulfed by white blood cells as 
compared to necrosis where cells rupture and the cell content affect the neighboring 
cells thus causing inflammation. The S.F extract in this study achieved the aim of 
apoptosis. 
Following the MTT assay, flow cytometry was employed to determine if the treated 
cells dies by apoptosis or necrosis, the two method of cell death were shown to be 
similar at a point in the process and the characteristics that differentiate the two are 
engulfment of phygocytotic cells in apoptosis and the cells swelling in necrosis which 
causes rupture resulting in inflammation and this may cause decreased blood flow at 
the affected area resulting in tissue death. Because of the above mentioned reasons, 
apoptosis is the preferred method of cell death as the programmed cell death 
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process that is regulated and controlled. Flow cytometry uses Annexin V that has a 
high calcium dependent affinity towards the phosphatidylserine (P.S). The stain 
detects the cells in the early apoptosis where cell membrane asymmetry is lost and 
the P.S translocate to the external membrane binding to Annexin V. Because 
Propidium iodide is not permeant to the viable cells, the dye intercalate into DNA 
base pairs when the DNA content are exposed. From Figure 4(B) significant high 
number of treated cell showed the phosphatidylserine residue externalization with an 
exception of Taxol treated cells that showed more cells are dying via necrosis than 
apoptosis. The 15% of cells were in Quadrant 4 as compared to 12% in Q1. 
 
The DNA content of the treated and non-treated cells was measured to confirm the 
phase of the cell cycle the plant had effect on. The results depicted in Figure 4(A) 
shows 40% of cells in G0/G1 and S phase for IC50 treated cells as compared to 49% 
and 39% in untreated cells. In the G0 phase, cells are carrying out their normal 
metabolic function but not replicating therefore there is no cell cycle. In the G1 
phase, cells produces proteins the cells need to grow and start replicating in the S 
phase .The results obtained from cell cycles shows cells are being arrested at the S 
phase as there are more cells in the G0/G1 Phase and less in the G2/M phase as 
compared to the S phase. Cells are being checked at the G1/S phase for any error 
and the found errors prevent cells from entering the G2/M phase where the cells are 
producing additional proteins, RNA and the mitotic spindle necessary for mitosis. 
The role of the cell cycle arrest is to prevent any errors occurred to proceed in the 
cell cycle as this will cause mutation which will have defects on the cells thus the 
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organism. Therefore the extract induced the cell cycle arrest in the S phase to allow 
cell repair before cell cycle continues. 
 
Caspases are a widely known executioner of apoptosis. When these proteins are 
involved, cell death is believed to be through apoptosis. The caspase 3/7 was 
employed following flow cytometry to confirm cells death induced by the extract. 
Taxol was used as a positive control and media only as untreated cells. The 
100µg/ml showed a significant high caspase 3/7 activity on the SiHa cells and the 
result shows the mode of action of the extract on the SiHa cells is caspase 
independent thus apoptosis. Untreated cells had a higher caspase 3/7 activity due to 
apoptosis being a normal programmed cell death that occur to balance the cells. 
Taxol widely known as paclitaxel is a known chemotherapeutic drug currently in use 
together with radiotherapy to reduce the risk of early-staged breast cancer re-curing 
as well as to treat advanced-staged breast cancer after it has stopped responding to 
standard chemotherapy regimens. Because Taxol has adverse side effects and is 
not easily soluble in water S.F becomes the promising anti-cancer agent with little 
side effects. Skerman et al, (2011) found similar results when esophageal cancer cell 
line (CCL-185) was treated with S.F. Further studied needs to be conducted to better 
understand the relationship between caspases and apoptosis as  there is 
accumulating information that suggests apoptosis is not caspase dependent (Broker 
et al, 2005). 
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Conclusion: Sutherlandia Frutescence has proven with number of research that it 
induces cell death via apoptosis. After evaluating its cytotoxicity, the plant shows to 
be a promising anti-tumour agent that needs to be clinically proven. 
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